SOX2 and neoplasm: The result may also be intrinsic to the SOX2+ nature of the bronchiolar organoids, as research in human cell lines has suggested SOX2 plays a role in osimertinib resistance.[45] However, the clinical relevance of this finding will require further investigation, including in vivo experiments testing the response of each tumor lineage to systemic therapy.